Market research
HEMP.F Deutsche Cannabis AG
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 3.05
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- DE000A0BVVK7
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 3.05
About
About Deutsche Cannabis AG
Deutsche Cannabis AG engages in the acquisition, sale, and management of investments in cannabis industry primarily in Germany. It also focuses on the investment in the renewable energy sector, such as photovoltaics and cogeneration. The company was formerly known as F.A.M.E. AG and changed its name to Deutsche Cannabis AG in December 2014. Deutsche Cannabis AG was founded in 1999 and is based in Hamburg, Germany.
Research context
Deutsche Cannabis AG appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the HEMP.F discussion.
5 years, 7 months ago
Deutsche Cannabis AG is currently in a long term downtrend where the price is trading 28.2% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Deutsche Cannabis AG gets an overall score of 1/5.